An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Top results in this bookTable of Contents
Holland-Frei Cancer Medicine. 6th edition.
Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.
Hamilton (ON): BC Decker; 2003.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
Pembrolizumab in Combination With Lenvatinib (Keytruda and Lenvima): CADTH Reimbursement Review: Therapeutic area: Advanced endometrial cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Dec.
Pembrolizumab (Keytruda): CADTH Reimbursement Review: Therapeutic area: Advanced endometrial cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Apr.
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial [Internet].
Menon U, Gentry-Maharaj A, Burnell M, et al.
Southampton (UK): National Institute for Health and Care Research; 2023 May.
Ovarian Cancer: The Recognition and Initial Management of Ovarian Cancer.
Cardiff (UK): National Collaborating Centre for Cancer (UK); 2011 Apr. (NICE Clinical Guidelines, No. 122.)
Madame Curie Bioscience Database [Internet].
Austin (TX): Landes Bioscience; 2000-2013.
NTP Research Report on Absence of Formaldehyde-Induced Neoplasia in Trp53 Haploinsufficient Mice Exposed by Inhalation: Research Report 3 [Internet].
Morgan DL, Dixon D, King DH, et al.
Durham (NC): National Toxicology Program; 2017 Aug.
Pembrolizumab (Keytruda) in Combination With Lenvatinib (Lenvima): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with advanced endometrial carcinoma that is not microsatellite instability high or mismatch repair deficient, who have disease progression following prior platinum-based systemic therapy, and are not candidates for curative surgery or radiation [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Sep.
Comparative Oncology.
Baba AI, Câtoi C.
Bucharest (RO): The Publishing House of the Romanian Academy; 2007.
Surgical Treatment: Evidence-Based and Problem-Oriented.
Holzheimer RG, Mannick JA, editors.
Munich: Zuckschwerdt; 2001.
Dostarlimab (Jemperli): Therapeutic area: endometrial cancer, in combination with carboplatin and paclitaxel: CADTH Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jul.
Comparing Surgeries for Women Who Have Both Cancer of the Uterus and Bladder Problems [Internet].
Robison K, Wohlrab K, Sung V, et al.
Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2020 Nov.
Benzene.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
Lyon (FR): International Agency for Research on Cancer; 2018. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 120.)
Some Pharmaceutical Drugs.
Lyon (FR): International Agency for Research on Cancer; 1996. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 66.)
Dostarlimab (Jemperli): CADTH Reimbursement Review: Therapeutic area: Endometrial cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Nov.
Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.
Cardiff (UK): National Collaborating Centre for Cancer (UK); 2010 Jul. (NICE Clinical Guidelines, No. 104.)
Carrier probability – people with ovarian cancer: Ovarian cancer: identifying and managing familial and genetic risk: Evidence review I.
London: National Institute for Health and Care Excellence (NICE); 2024 Mar. (NICE Guideline, No. 241.)
NTP Technical Report on the Toxicology and Carcinogenesis Studies of 2,3-Butanedione (CASRN 431-03-8) in Wistar Han [Crl:WI (Han)] Rats and B6C3F1/N Mice (Inhalation Studies): Technical Report 593 [Internet].
National Toxicology Program.
Research Triangle Park (NC): National Toxicology Program; 2018 Aug.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on